Cargando…
Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century
INTRODUCTION: The advent of tyrosine kinase inhibitors has produced 5-year survival of 90 + % for chronic myelocytic leukemia (CML) patients in clinical trials. However, population level survival has been lower, especially in older patients. Here, we examine survival of patients with CML in Germany...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848850/ https://www.ncbi.nlm.nih.gov/pubmed/24499592 http://dx.doi.org/10.1186/1756-8722-6-70 |